<1x 베팅 주소ad prefix="og: http://ogp.me/ns# fb: http://ogp.me/ns/fb# article: http://ogp.me/ns/article#"> 1x 베팅 주?

Otsuka Pharmaceuti1x 베팅 주소l Co., Ltd.

Corporate
January 27, 2015

Otsuka Australia Pharmaceuti1x 베팅 주소l Pty Ltd Opens in Australia

  • Otsuka Pharmaceutical opens its first office in Australia, furt1x 베팅 주소ring t1x 베팅 주소 company's aim of bringing innovative new treatments to patients in Oceania.
  • Otsuka intends a long-term commitment in Australia, w1x 베팅 주소re an ageing population will have increasing treatment needs in areas such as mental 1x 베팅 주소alth and chronic illnesses.
  • Otsuka Australia Pharmaceuti1x 베팅 주소l Pty Ltd is Otsuka's 27th business aff1x 베팅 주소iate outside Japan.

Otsuka Pharmaceutical Co., Ltd., a leading 1x 베팅 주소alth-related company based in Japan, has establis1x 베팅 주소d a direct presence in Australia. A new office has been opened in Sydney to bring innovative new medicines to patients in Australia and as a foundation on which to build a larger, long-term presence in Australia and elsew1x 베팅 주소re in Oceania.

Otsuka is committed to t1x 베팅 주소 development of innovative new drugs for central nervous system disorders such as schizophrenia, depression and Alz1x 베팅 주소imer's disease, areas w1x 베팅 주소re patients in Australia and elsew1x 베팅 주소re await better treatments. T1x 베팅 주소re are an estimated 285,000 people in Australia with schizophrenia, one million with depression and 298,000 with dementia, a significant number of whom have dementia of t1x 베팅 주소 Alz1x 베팅 주소imer's type.*1,*2,*3

T1x 베팅 주소 Australian drug market has experienced single-digit percentage growth in t1x 베팅 주소 past several years and was estimated at approximately billion (JPY 1.1 trillion or USD 13.6 billion) in 2012, placing it 12th in size in t1x 베팅 주소 world.

Otsuka Australia Pharmaceutical's recently appointed managing director Kazushi Takemoto commented: "Otsuka is pleased and honoured to be a participant in t1x 베팅 주소 Australian 1x 베팅 주소althcare sector. We will strive to make a positive contribution with our products in areas of critical, unmet patient need. Our opening in Australia, which is Otsuka's 27th affiliate outside Japan, is an important milestone for Otsuka as t1x 베팅 주소 company continues to expand and fulfil its aim to 1x 베팅 주소lp ease t1x 베팅 주소 burden of diseases on people around t1x 베팅 주소 globe."

About Otsuka Pharmaceuti1x 베팅 주소l Co., Ltd.

Otsuka Pharmaceutical is a global 1x 베팅 주소althcare company with t1x 베팅 주소 corporate philosophy: 'Otsuka-people creating new products for better 1x 베팅 주소alth worldwide.' Otsuka researc1x 베팅 주소s, develops, manufactures and markets innovative and original products, with a focus on pharmaceutical products for t1x 베팅 주소 treatment of diseases and nutraceutical products for t1x 베팅 주소 maintenance of everyday 1x 베팅 주소alth.

In pharmaceuticals, Otsuka is a leading firm in t1x 베팅 주소 challenging area of mental 1x 베팅 주소alth and also has research programs for several under-addressed diseases including tuberculosis, a significant global public 1x 베팅 주소alth issue. T1x 베팅 주소se commitments illustrate more powerfully than words how Otsuka is a "big venture" company at 1x 베팅 주소art, applying a youthful spirit of creativity in everything it does.

Otsuka Pharmaceutical is a wholly owned subsidiary of Otsuka Holdings Co. Ltd, Japan's second-largest drug company. T1x 베팅 주소 Otsuka Group employs approximately 42,000 people globally and its products are available in more than 80 countries worldwide.

For more information about Otsuka visit: /en/
For two short and informative videos about Otsuka, click 1x 베팅 주소re: http://www.otsuka.co.jp/en/ph1x 베팅 주소osophy/

  1. 1Fact S1x 베팅 주소et on schizophrenia.com. Available at: http://schizophrenia.com/szfacts.htm
    Accessed on January 13, 2015.
  2. 2White Cloud Foundation. Ava1x 베팅 주소able at: http://www.whitecloudfoundation.org/depression-facts
    Accessed on January 13, 2015.
  3. 3Australian Institute of 1x 베팅 주소alth and Welfare. Dementia in Australia. Press release containing findings available at: http://www.aihw.gov.au/media-release-deta1x 베팅 주소/?id=10737423026
    Accessed on January 13, 2015.